Stockreport

Edgewise Therapeutics to Present on EDG-5506 for the Treatment of Becker Muscular Dystrophy at the 2024 MDA Clinical and Scientific Conference [Yahoo! Finance]

Edgewise Therapeutics, Inc.  (EWTX) 
PDF BOULDER, Colo., February 28, 2024 BUSINESS WIRE )--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that [Read more]